Telegraph Hill Partners
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio0 active
4Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Gossamer Bio
49Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Gossamer Bio | Biotech | Public | Sep 4, 2026 | $728.1M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Kiniksa Pharmaceuticals | Biotech | Public | Nov 23, 2020 | $5.9M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
Peer ranks
Portfolio size#108
Portfolio exits#49
Raises, 12 months#22
Co-investors#29
Co-investors
- Gurnet Point CapitalVenture capital2 shared
- Lightstone VenturesVenture capital2 shared
- Omega FundsVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Thomas, McNerney & PartnersVenture capital2 shared
- XontogenyVenture capital2 shared
- Aisling CapitalVenture capital1 shared
- Alexandria Venture InvestmentsVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- Ascent Biomedical VenturesVenture capital1 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.